American Oriental Bioengineering Reports Second Quarter 2009 Financi...(marketing 9396129 7687892 ...)

Date:8/7/2009

marketing 9,396,129 7,687,892 14,607,631 12,717,600 Advertising 7,779,936 7,452,231 13,347,293 11,846,572 General and administrative 4,315,714 5,253,274 8,881,357 9,165,957 Depreciation and amortization 1,850,274 1,010,461 3,709,189 1,987,671 Total operating expenses 23,342,053 21,403,858 40,545,470 35,717,800 INCOME FROM OPERATIONS 18,285,061 18,677,700 29,498,496 30,654,720 EQUITY IN EARNINGS (LOSS) FROM UNCONSOLIDATED ENTITIES (173,258) (640,008) 264,536 (641,067) INTEREST INCOME (EXPENSE), NET (1,620,069) (30,616) (3,199,338) (13,769) OTHER INCOME (EXPENSE), NET (16,329) (255,770) (114,938) (356,502) INCOME BEFORE INCOME TAXES 16,475,405 17,751,306 26,448,756 29,643,382 INCOME TAXES 3,369,107 3,891,614 5,472,406 6,361,562 NET INCOME 13,106,298 13,859,692 20,976,350 23,281,820 NET INCOME ATTRIBUTABLE TO NON- CONTROLLING INTEREST 123,068 -- 119,517 -- NET INCOME ATTRIBUTABLE TO CONTROLLING INTEREST 13,229,366 13,859,692 21,095,867 23,281,820 OTHER COMPREHENSIVE INCOME Foreign currency translation gain, net of tax 46,316 5,154,761 424,782 12,089,196 TOTAL OTHER COMPREHENSIVE INCOME, NET OF TAX 46,316 5,154,761 424,782 12,089,196 COMPREHENSIVE INCOME $13,275,682 $19,014,453 $21,520,649 $35,371,016 NET INCOME PER SHARE BASIC $0.18 $0.18 $0.28 $0.30 DILUTED $0.17 $0.18 $0.28 $0.30 WEIGHTED AVERAGE NUMBER O
'/>"/>

SOURCE American Oriental Bioengineering, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance